Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Schering-Plough
|
| gptkbp:acquisitionYear |
2007
|
| gptkbp:country |
gptkb:Netherlands
|
| gptkbp:focusArea |
biosimilars
women's health established brands |
| gptkbp:founded |
1923
|
| gptkbp:founder |
gptkb:Saalt_van_Zwanenberg
|
| gptkbp:headquarters_location |
gptkb:Oss,_Netherlands
|
| https://www.w3.org/2000/01/rdf-schema#label |
Organon Pharmaceuticals
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:notableProduct |
gptkb:Depo-Provera
gptkb:Follistim gptkb:NuvaRing gptkb:Puregon gptkb:Marvelon |
| gptkbp:parentCompany |
gptkb:Merck_&_Co.
|
| gptkbp:spin-off_year |
2021
|
| gptkbp:spinOff |
gptkb:Merck_&_Co.
|
| gptkbp:stockExchange |
gptkb:NYSE
|
| gptkbp:stockSymbol |
gptkb:OGN
|
| gptkbp:website |
https://www.organon.com/
|
| gptkbp:bfsParent |
gptkb:Margaret_Crane
|
| gptkbp:bfsLayer |
6
|